Diego J. Maselli, MD, FCCP

COPD Highlights From ATS 2024

Publish date: June 11, 2024

Highlights in chronic obstructive pulmonary disease (COPD) ATS 2024 include therapeutics tezepelumab, dupilumab, and ensifentrine.